Search
for
Sort by
Research 151–180 of 1000+
- COVID-19 Pandemic is Not Over for Survivors with Long COVID Syndrome: Evidence of a One-Year Retrospective Follow-up Study from Iran
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- Hypoxia inducible factor-1α promotes trichogenic gene expression in human dermal papilla cells
- Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia
- Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
- Production of a 135-residue long N-truncated human keratinocyte growth factor 1 in Escherichia coli
- Not just thinning: A case of alopecia universalis after mild COVID-19
- Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- COVID-19 pandemic and teledermatology in low-income regions
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- A comment on psychological distress and women’s hair loss related to the COVID-19 pandemic
- COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- A response to “Male balding is a major risk factor for severe COVID-19”
- Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
- Viewpoint 1
- Alopecia in a 19-Month-Old Boy
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Examining the long‐term effects of COVID‐19 in surgical nurses: Case of Aegean Region
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil